

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | humoral immune response (GO:0006959) | 9.15900466 |
| 2 | positive regulation of respiratory burst (GO:0060267) | 7.27579447 |
| 3 | glomerular filtration (GO:0003094) | 6.53212120 |
| 4 | negative regulation of glucose import (GO:0046325) | 6.19663050 |
| 5 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 6.10801474 |
| 6 | signal peptide processing (GO:0006465) | 5.94345280 |
| 7 | keratinization (GO:0031424) | 5.87596302 |
| 8 | renal filtration (GO:0097205) | 5.81706075 |
| 9 | cytidine deamination (GO:0009972) | 5.49555545 |
| 10 | cytidine metabolic process (GO:0046087) | 5.49555545 |
| 11 | cytidine catabolic process (GO:0006216) | 5.49555545 |
| 12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.45389265 |
| 13 | B cell receptor signaling pathway (GO:0050853) | 5.41378302 |
| 14 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 5.28401004 |
| 15 | negative regulation of B cell proliferation (GO:0030889) | 5.12203385 |
| 16 | negative regulation of glucose transport (GO:0010829) | 5.00374253 |
| 17 | regulation of respiratory burst (GO:0060263) | 4.89044591 |
| 18 | detection of bacterium (GO:0016045) | 4.88734625 |
| 19 | detection of other organism (GO:0098543) | 4.80029983 |
| 20 | Fc-epsilon receptor signaling pathway (GO:0038095) | 4.68740765 |
| 21 | Fc receptor signaling pathway (GO:0038093) | 4.68013699 |
| 22 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 4.63112991 |
| 23 | cellular response to zinc ion (GO:0071294) | 4.34355538 |
| 24 | positive regulation of B cell differentiation (GO:0045579) | 4.32031898 |
| 25 | phenylpropanoid metabolic process (GO:0009698) | 4.25246963 |
| 26 | immune response-regulating cell surface receptor signaling pathway (GO:0002768) | 4.23447156 |
| 27 | immunoglobulin mediated immune response (GO:0016064) | 4.21930879 |
| 28 | regulation of B cell proliferation (GO:0030888) | 4.13745365 |
| 29 | germinal center formation (GO:0002467) | 4.01531398 |
| 30 | fucose catabolic process (GO:0019317) | 4.01395213 |
| 31 | L-fucose metabolic process (GO:0042354) | 4.01395213 |
| 32 | L-fucose catabolic process (GO:0042355) | 4.01395213 |
| 33 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.91953010 |
| 34 | regulation of water loss via skin (GO:0033561) | 3.86975392 |
| 35 | establishment of skin barrier (GO:0061436) | 3.86594852 |
| 36 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.83836132 |
| 37 | immune response-activating signal transduction (GO:0002757) | 3.83405107 |
| 38 | regulation of B cell differentiation (GO:0045577) | 3.81143891 |
| 39 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.72928059 |
| 40 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.72928059 |
| 41 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.61241665 |
| 42 | proline biosynthetic process (GO:0006561) | 3.57071321 |
| 43 | positive regulation of macrophage cytokine production (GO:0060907) | 3.54318297 |
| 44 | detection of external biotic stimulus (GO:0098581) | 3.50997040 |
| 45 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.50753406 |
| 46 | activation of immune response (GO:0002253) | 3.46861803 |
| 47 | cellular response to type I interferon (GO:0071357) | 3.36702089 |
| 48 | type I interferon signaling pathway (GO:0060337) | 3.36702089 |
| 49 | negative thymic T cell selection (GO:0045060) | 3.36584632 |
| 50 | interferon-gamma secretion (GO:0072643) | 3.36188616 |
| 51 | response to type I interferon (GO:0034340) | 3.33654212 |
| 52 | regulation of cellular extravasation (GO:0002691) | 3.30425346 |
| 53 | response to protozoan (GO:0001562) | 3.30297489 |
| 54 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.27575307 |
| 55 | positive regulation of immunoglobulin production (GO:0002639) | 3.26312092 |
| 56 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.25137268 |
| 57 | B cell mediated immunity (GO:0019724) | 3.24366807 |
| 58 | B cell proliferation (GO:0042100) | 3.21097788 |
| 59 | surfactant homeostasis (GO:0043129) | 3.21047652 |
| 60 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.19772431 |
| 61 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.19171742 |
| 62 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.19171742 |
| 63 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.15181713 |
| 64 | regulation of antigen processing and presentation (GO:0002577) | 3.12156461 |
| 65 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.10039781 |
| 66 | defense response to protozoan (GO:0042832) | 3.09064772 |
| 67 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.07639061 |
| 68 | negative T cell selection (GO:0043383) | 3.05421147 |
| 69 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.02629837 |
| 70 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.02476815 |
| 71 | detection of biotic stimulus (GO:0009595) | 3.01029798 |
| 72 | complement activation, classical pathway (GO:0006958) | 26.6065779 |
| 73 | complement activation (GO:0006956) | 20.4074570 |
| 74 | chronic inflammatory response (GO:0002544) | 2.99195779 |
| 75 | regulation of regulatory T cell differentiation (GO:0045589) | 2.93610048 |
| 76 | cellular extravasation (GO:0045123) | 2.92530649 |
| 77 | regulation of T cell tolerance induction (GO:0002664) | 2.90427497 |
| 78 | positive regulation of antigen processing and presentation (GO:0002579) | 2.89073290 |
| 79 | negative regulation of B cell activation (GO:0050869) | 2.87825869 |
| 80 | regulation of B cell apoptotic process (GO:0002902) | 2.85520688 |
| 81 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.85187608 |
| 82 | negative regulation of cell killing (GO:0031342) | 2.85187608 |
| 83 | regulation of B cell activation (GO:0050864) | 2.84590999 |
| 84 | regulation of germinal center formation (GO:0002634) | 2.82493181 |
| 85 | multicellular organismal water homeostasis (GO:0050891) | 2.80580655 |
| 86 | keratinocyte differentiation (GO:0030216) | 2.80462914 |
| 87 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.79662470 |
| 88 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.75697783 |
| 89 | Golgi transport vesicle coating (GO:0048200) | 2.74967597 |
| 90 | COPI coating of Golgi vesicle (GO:0048205) | 2.74967597 |
| 91 | mast cell activation (GO:0045576) | 2.72506654 |
| 92 | tissue homeostasis (GO:0001894) | 2.70624846 |
| 93 | cellular response to interferon-gamma (GO:0071346) | 2.69077033 |
| 94 | skin morphogenesis (GO:0043589) | 2.68074744 |
| 95 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.67486351 |
| 96 | respiratory burst (GO:0045730) | 2.67457752 |
| 97 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.67203582 |
| 98 | positive regulation of protein homooligomerization (GO:0032464) | 2.66309656 |
| 99 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.66210697 |
| 100 | positive regulation of T cell chemotaxis (GO:0010820) | 2.63732326 |
| 101 | regulation of T cell chemotaxis (GO:0010819) | 2.63732326 |
| 102 | positive regulation of tolerance induction (GO:0002645) | 2.63272024 |
| 103 | peptidyl-asparagine modification (GO:0018196) | 2.62800052 |
| 104 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.62395499 |
| 105 | regulation of tolerance induction (GO:0002643) | 2.62159824 |
| 106 | positive regulation of granulocyte chemotaxis (GO:0071624) | 2.60551474 |
| 107 | positive T cell selection (GO:0043368) | 2.59618812 |
| 108 | response to interleukin-15 (GO:0070672) | 2.57658636 |
| 109 | production of molecular mediator of immune response (GO:0002440) | 2.54119257 |
| 110 | peptide cross-linking (GO:0018149) | 2.52180144 |
| 111 | regulation of integrin activation (GO:0033623) | 2.51986388 |
| 112 | thymic T cell selection (GO:0045061) | 2.51933056 |
| 113 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.51200261 |
| 114 | lipoxygenase pathway (GO:0019372) | 2.51020014 |
| 115 | negative regulation of cellular response to insulin stimulus (GO:1900077) | 2.50830888 |
| 116 | water homeostasis (GO:0030104) | 2.50184573 |
| 117 | T-helper 1 type immune response (GO:0042088) | 2.50179397 |
| 118 | defense response to Gram-negative bacterium (GO:0050829) | 2.49967737 |
| 119 | positive regulation of type 2 immune response (GO:0002830) | 2.49734349 |
| 120 | protein-chromophore linkage (GO:0018298) | 2.48788857 |
| 121 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.48375587 |
| 122 | superoxide anion generation (GO:0042554) | 2.46704619 |
| 123 | daunorubicin metabolic process (GO:0044597) | 2.45789669 |
| 124 | polyketide metabolic process (GO:0030638) | 2.45789669 |
| 125 | doxorubicin metabolic process (GO:0044598) | 2.45789669 |
| 126 | protein N-linked glycosylation (GO:0006487) | 2.44926700 |
| 127 | neutrophil activation involved in immune response (GO:0002283) | 2.44760175 |
| 128 | response to interferon-gamma (GO:0034341) | 2.44519268 |
| 129 | antibacterial humoral response (GO:0019731) | 2.44475036 |
| 130 | regulation of gamma-delta T cell activation (GO:0046643) | 2.42782254 |
| 131 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.42473361 |
| 132 | positive regulation of T cell migration (GO:2000406) | 2.41720350 |
| 133 | maternal placenta development (GO:0001893) | 2.41012406 |
| 134 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.40920808 |
| 135 | regulation of macrophage cytokine production (GO:0010935) | 2.39640917 |
| 136 | regulation of natural killer cell differentiation (GO:0032823) | 2.38163194 |
| 137 | regulation of immunoglobulin production (GO:0002637) | 2.36707701 |
| 138 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.34696593 |
| 139 | positive regulation of Rap GTPase activity (GO:0032854) | 2.34106130 |
| 140 | proline metabolic process (GO:0006560) | 2.33191950 |
| 141 | xenobiotic catabolic process (GO:0042178) | 2.32631847 |
| 142 | negative regulation of B cell apoptotic process (GO:0002903) | 2.31477020 |
| 143 | positive regulation of production of molecular mediator of immune response (GO:0002702) | 2.31093270 |
| 144 | positive regulation of nuclease activity (GO:0032075) | 2.30263161 |
| 145 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.29834957 |
| 146 | antimicrobial humoral response (GO:0019730) | 2.29146484 |
| 147 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.28793231 |
| 148 | regulation of nuclease activity (GO:0032069) | 2.28431735 |
| 149 | N-acetylneuraminate metabolic process (GO:0006054) | 2.28252273 |
| 150 | positive thymic T cell selection (GO:0045059) | 2.28208940 |
| 151 | bone resorption (GO:0045453) | 2.27500772 |
| 152 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.25557310 |
| 153 | cellular response to unfolded protein (GO:0034620) | 2.24323852 |
| 154 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.24106025 |
| 155 | B cell homeostasis (GO:0001782) | 2.22970073 |
| 156 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.21893262 |
| 157 | T cell selection (GO:0045058) | 2.19953011 |
| 158 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.14578833 |
| 159 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.12289804 |
| 160 | positive regulation of B cell activation (GO:0050871) | 2.11532901 |
| 161 | gonadal mesoderm development (GO:0007506) | 13.7156402 |
| 162 | protein activation cascade (GO:0072376) | 13.2722674 |
| 163 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 11.2296838 |
| 164 | Fc-gamma receptor signaling pathway (GO:0038094) | 11.2296838 |
| 165 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 11.2296838 |
| 166 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 11.0920128 |
| 167 | retina homeostasis (GO:0001895) | 10.3952862 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.14213542 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.05385108 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.94151732 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.66230312 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.41744716 |
| 6 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.88159083 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 3.82946288 |
| 8 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.81023910 |
| 9 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.74168694 |
| 10 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 3.43186440 |
| 11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.35104984 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.18991992 |
| 13 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.07823927 |
| 14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.90352778 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.85425628 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.75009110 |
| 17 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.64620976 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.64263927 |
| 19 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.47024424 |
| 20 | MAF_26560356_Chip-Seq_TH1_Human | 2.35506582 |
| 21 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.34495145 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.33899756 |
| 23 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.18682846 |
| 24 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.13216657 |
| 25 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.09063576 |
| 26 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.06961025 |
| 27 | MYB_26560356_Chip-Seq_TH2_Human | 1.99836119 |
| 28 | MYB_26560356_Chip-Seq_TH1_Human | 1.97722730 |
| 29 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.93207549 |
| 30 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.89365055 |
| 31 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.86679575 |
| 32 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.82834866 |
| 33 | GATA1_22025678_ChIP-Seq_K562_Human | 1.75812206 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.74251302 |
| 35 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.73192787 |
| 36 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.72799022 |
| 37 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.69636322 |
| 38 | UTX_26944678_Chip-Seq_JUKART_Human | 1.65585894 |
| 39 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.62676875 |
| 40 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.62567128 |
| 41 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.59883614 |
| 42 | GATA3_26560356_Chip-Seq_TH2_Human | 1.59883451 |
| 43 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.58731228 |
| 44 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.55690146 |
| 45 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.55179859 |
| 46 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.54721272 |
| 47 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.53486370 |
| 48 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.52233662 |
| 49 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.49388749 |
| 50 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.47558591 |
| 51 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.46054167 |
| 52 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.45607899 |
| 53 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.45294257 |
| 54 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.42771901 |
| 55 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.42333110 |
| 56 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.42041550 |
| 57 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37363506 |
| 58 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35892068 |
| 59 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.35875811 |
| 60 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.35754183 |
| 61 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.34673483 |
| 62 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.30063708 |
| 63 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.29056936 |
| 64 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.28880268 |
| 65 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.28657044 |
| 66 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.26155658 |
| 67 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20463319 |
| 68 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.19945365 |
| 69 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19417615 |
| 70 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.19235425 |
| 71 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.19164806 |
| 72 | MAF_26560356_Chip-Seq_TH2_Human | 1.18183812 |
| 73 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.18112721 |
| 74 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.17726010 |
| 75 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.15379470 |
| 76 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.13500849 |
| 77 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.13417664 |
| 78 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.12747273 |
| 79 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.11842003 |
| 80 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09962493 |
| 81 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.09441179 |
| 82 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09366664 |
| 83 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.07918737 |
| 84 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.07272539 |
| 85 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.05893009 |
| 86 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.05542905 |
| 87 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.04891923 |
| 88 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.04850541 |
| 89 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04805246 |
| 90 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.04338997 |
| 91 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.04289544 |
| 92 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03811446 |
| 93 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03012165 |
| 94 | GATA1_19941826_ChIP-Seq_K562_Human | 1.02784508 |
| 95 | SPI1_23127762_ChIP-Seq_K562_Human | 1.02736080 |
| 96 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.00699577 |
| 97 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.00189488 |
| 98 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.98468628 |
| 99 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.97940464 |
| 100 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.97386249 |
| 101 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.96510884 |
| 102 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.95083317 |
| 103 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.93811356 |
| 104 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.93494433 |
| 105 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.93194022 |
| 106 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.92197528 |
| 107 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91941064 |
| 108 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.90254877 |
| 109 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.88157831 |
| 110 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.88125705 |
| 111 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.87932886 |
| 112 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.87899212 |
| 113 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.87748777 |
| 114 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.87592850 |
| 115 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86807842 |
| 116 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.85708817 |
| 117 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.82943422 |
| 118 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.82914339 |
| 119 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82829468 |
| 120 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.82625254 |
| 121 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.82625254 |
| 122 | GATA2_19941826_ChIP-Seq_K562_Human | 0.82591582 |
| 123 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81716390 |
| 124 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81657967 |
| 125 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.81130196 |
| 126 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81122097 |
| 127 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.80482444 |
| 128 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.79833308 |
| 129 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.79758955 |
| 130 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.78982255 |
| 131 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78852843 |
| 132 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.78740517 |
| 133 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.78552397 |
| 134 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.78159210 |
| 135 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.77793418 |
| 136 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.77348375 |
| 137 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.76566050 |
| 138 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.75040801 |
| 139 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.74964341 |
| 140 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.74873622 |
| 141 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.73199535 |
| 142 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.72665147 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.69891578 |
| 2 | MP0001800_abnormal_humoral_immune | 4.75674862 |
| 3 | MP0003303_peritoneal_inflammation | 4.18701489 |
| 4 | MP0003724_increased_susceptibility_to | 3.96835030 |
| 5 | MP0005671_abnormal_response_to | 3.70529844 |
| 6 | MP0005387_immune_system_phenotype | 3.51558506 |
| 7 | MP0001790_abnormal_immune_system | 3.51558506 |
| 8 | MP0002452_abnormal_antigen_presenting | 3.38196416 |
| 9 | MP0002796_impaired_skin_barrier | 2.98576292 |
| 10 | MP0002723_abnormal_immune_serum | 2.90987555 |
| 11 | MP0002420_abnormal_adaptive_immunity | 2.75070076 |
| 12 | MP0001819_abnormal_immune_cell | 2.69239641 |
| 13 | MP0005275_abnormal_skin_tensile | 2.60267428 |
| 14 | MP0006054_spinal_hemorrhage | 2.59874854 |
| 15 | MP0000685_abnormal_immune_system | 2.59263491 |
| 16 | MP0002398_abnormal_bone_marrow | 2.59165047 |
| 17 | MP0005000_abnormal_immune_tolerance | 2.56189794 |
| 18 | MP0000716_abnormal_immune_system | 2.53298690 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 2.44528142 |
| 20 | MP0002166_altered_tumor_susceptibility | 2.42832438 |
| 21 | MP0000689_abnormal_spleen_morphology | 2.20071388 |
| 22 | MP0010234_abnormal_vibrissa_follicle | 2.08905113 |
| 23 | MP0005025_abnormal_response_to | 2.06805748 |
| 24 | MP0002429_abnormal_blood_cell | 2.06306814 |
| 25 | MP0002139_abnormal_hepatobiliary_system | 1.89203035 |
| 26 | MP0002006_tumorigenesis | 1.89033123 |
| 27 | MP0002419_abnormal_innate_immunity | 1.85590894 |
| 28 | MP0001879_abnormal_lymphatic_vessel | 1.81052149 |
| 29 | MP0002722_abnormal_immune_system | 1.80013500 |
| 30 | MP0008438_abnormal_cutaneous_collagen | 1.79973557 |
| 31 | MP0002138_abnormal_hepatobiliary_system | 1.77746298 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.77373343 |
| 33 | MP0004947_skin_inflammation | 1.75641558 |
| 34 | MP0002876_abnormal_thyroid_physiology | 1.74313421 |
| 35 | MP0005360_urolithiasis | 1.69927619 |
| 36 | MP0003436_decreased_susceptibility_to | 1.69231210 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.67034954 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.63437588 |
| 39 | MP0005166_decreased_susceptibility_to | 1.59783917 |
| 40 | MP0003453_abnormal_keratinocyte_physiol | 1.58995767 |
| 41 | MP0004782_abnormal_surfactant_physiolog | 1.58413632 |
| 42 | MP0003300_gastrointestinal_ulcer | 1.54444827 |
| 43 | MP0005501_abnormal_skin_physiology | 1.50791674 |
| 44 | MP0003763_abnormal_thymus_physiology | 1.46470748 |
| 45 | MP0000465_gastrointestinal_hemorrhage | 1.44893343 |
| 46 | MP0002405_respiratory_system_inflammati | 1.42303702 |
| 47 | MP0002060_abnormal_skin_morphology | 1.38100636 |
| 48 | MP0000920_abnormal_myelination | 1.37952521 |
| 49 | MP0008004_abnormal_stomach_pH | 1.33988354 |
| 50 | MP0000858_altered_metastatic_potential | 1.33201086 |
| 51 | MP0009785_altered_susceptibility_to | 1.32848429 |
| 52 | MP0005310_abnormal_salivary_gland | 1.31831492 |
| 53 | MP0005085_abnormal_gallbladder_physiolo | 1.29109206 |
| 54 | MP0002396_abnormal_hematopoietic_system | 1.27131553 |
| 55 | MP0006082_CNS_inflammation | 1.27075267 |
| 56 | MP0010155_abnormal_intestine_physiology | 1.26490747 |
| 57 | MP0003183_abnormal_peptide_metabolism | 1.25741832 |
| 58 | MP0002933_joint_inflammation | 1.24067926 |
| 59 | MP0000013_abnormal_adipose_tissue | 1.23452884 |
| 60 | MP0009046_muscle_twitch | 1.20942016 |
| 61 | MP0004264_abnormal_extraembryonic_tissu | 1.18625209 |
| 62 | MP0003045_fibrosis | 1.16897848 |
| 63 | MP0001851_eye_inflammation | 1.16655080 |
| 64 | MP0001853_heart_inflammation | 1.15305966 |
| 65 | MP0004510_myositis | 1.14651168 |
| 66 | MP0003448_altered_tumor_morphology | 1.12913259 |
| 67 | MP0004859_abnormal_synaptic_plasticity | 1.10395616 |
| 68 | MP0001216_abnormal_epidermal_layer | 1.09982574 |
| 69 | MP0008569_lethality_at_weaning | 1.09648366 |
| 70 | MP0002019_abnormal_tumor_incidence | 1.09494106 |
| 71 | MP0003566_abnormal_cell_adhesion | 1.05949913 |
| 72 | MP0010352_gastrointestinal_tract_polyps | 1.05436442 |
| 73 | MP0003866_abnormal_defecation | 1.03870306 |
| 74 | MP0009764_decreased_sensitivity_to | 1.02974063 |
| 75 | MP0001873_stomach_inflammation | 1.02900757 |
| 76 | MP0000343_altered_response_to | 1.02896729 |
| 77 | MP0008057_abnormal_DNA_replication | 1.02630217 |
| 78 | MP0003279_aneurysm | 1.02577245 |
| 79 | MP0003075_altered_response_to | 1.02186652 |
| 80 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.01222551 |
| 81 | MP0008872_abnormal_physiological_respon | 0.98073634 |
| 82 | MP0000377_abnormal_hair_follicle | 0.96714842 |
| 83 | MP0003941_abnormal_skin_development | 0.96473624 |
| 84 | MP0005464_abnormal_platelet_physiology | 0.96436198 |
| 85 | MP0004043_abnormal_pH_regulation | 0.96408738 |
| 86 | MP0000703_abnormal_thymus_morphology | 0.96307020 |
| 87 | MP0002136_abnormal_kidney_physiology | 0.92464144 |
| 88 | MP0002098_abnormal_vibrissa_morphology | 0.92235292 |
| 89 | MP0001348_abnormal_lacrimal_gland | 0.90779105 |
| 90 | MP0010771_integument_phenotype | 0.89962943 |
| 91 | MP0010678_abnormal_skin_adnexa | 0.88312191 |
| 92 | MP0000579_abnormal_nail_morphology | 0.87615354 |
| 93 | MP0005332_abnormal_amino_acid | 0.87521825 |
| 94 | MP0003186_abnormal_redox_activity | 0.86927852 |
| 95 | MP0001919_abnormal_reproductive_system | 0.86838677 |
| 96 | MP0005164_abnormal_response_to | 0.86586215 |
| 97 | MP0001545_abnormal_hematopoietic_system | 0.84601722 |
| 98 | MP0005397_hematopoietic_system_phenotyp | 0.84601722 |
| 99 | MP0008469_abnormal_protein_level | 0.84417223 |
| 100 | MP0002998_abnormal_bone_remodeling | 0.83163519 |
| 101 | MP0000609_abnormal_liver_physiology | 0.82620009 |
| 102 | MP0009931_abnormal_skin_appearance | 0.82239238 |
| 103 | MP0003690_abnormal_glial_cell | 0.81981718 |
| 104 | MP0000003_abnormal_adipose_tissue | 0.81729366 |
| 105 | MP0003656_abnormal_erythrocyte_physiolo | 0.81487992 |
| 106 | MP0005623_abnormal_meninges_morphology | 0.80765639 |
| 107 | MP0008875_abnormal_xenobiotic_pharmacok | 0.78958629 |
| 108 | MP0000249_abnormal_blood_vessel | 0.78093681 |
| 109 | MP0002877_abnormal_melanocyte_morpholog | 0.78083432 |
| 110 | MP0003828_pulmonary_edema | 0.77998315 |
| 111 | MP0005381_digestive/alimentary_phenotyp | 0.77860833 |
| 112 | MP0005390_skeleton_phenotype | 0.77793089 |
| 113 | MP0002277_abnormal_respiratory_mucosa | 0.77432167 |
| 114 | MP0000490_abnormal_crypts_of | 0.76297501 |
| 115 | MP0005451_abnormal_body_composition | 0.75965218 |
| 116 | MP0009643_abnormal_urine_homeostasis | 0.74693097 |
| 117 | MP0003879_abnormal_hair_cell | 0.74146045 |
| 118 | MP0003795_abnormal_bone_structure | 0.73777778 |
| 119 | MP0003252_abnormal_bile_duct | 0.72583217 |
| 120 | MP0001666_abnormal_nutrient_absorption | 0.71641995 |
| 121 | MP0009278_abnormal_bone_marrow | 0.70729636 |
| 122 | MP0005388_respiratory_system_phenotype | 0.69514763 |
| 123 | MP0002133_abnormal_respiratory_system | 0.69514763 |
| 124 | MP0002083_premature_death | 0.68660651 |
| 125 | MP0004858_abnormal_nervous_system | 0.68179560 |
| 126 | MP0001191_abnormal_skin_condition | 0.67385073 |
| 127 | MP0001986_abnormal_taste_sensitivity | 0.67283411 |
| 128 | MP0008260_abnormal_autophagy | 0.67210185 |
| 129 | MP0005083_abnormal_biliary_tract | 0.65984808 |
| 130 | MP0003091_abnormal_cell_migration | 0.64486227 |
| 131 | MP0004381_abnormal_hair_follicle | 0.63325986 |
| 132 | MP0010329_abnormal_lipoprotein_level | 0.62892048 |
| 133 | MP0001663_abnormal_digestive_system | 0.62398853 |
| 134 | MP0004147_increased_porphyrin_level | 0.61401455 |
| 135 | MP0009840_abnormal_foam_cell | 0.60934237 |
| 136 | MP0000604_amyloidosis | 0.60835441 |
| 137 | MP0003880_abnormal_central_pattern | 0.60658932 |
| 138 | MP0009763_increased_sensitivity_to | 0.60310597 |
| 139 | MP0002254_reproductive_system_inflammat | 0.59926280 |
| 140 | MP0005023_abnormal_wound_healing | 0.58095292 |
| 141 | MP0005365_abnormal_bile_salt | 0.57426461 |
| 142 | MP0001958_emphysema | 0.55326536 |
| 143 | MP0002693_abnormal_pancreas_physiology | 0.54720252 |
| 144 | MP0001533_abnormal_skeleton_physiology | 0.54386161 |
| 145 | MP0008873_increased_physiological_sensi | 0.52963913 |
| 146 | MP0003806_abnormal_nucleotide_metabolis | 0.52244581 |
| 147 | MP0005058_abnormal_lysosome_morphology | 0.51717592 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 9.27088124 |
| 2 | Prostate neoplasm (HP:0100787) | 8.17002836 |
| 3 | Abnormality of B cell number (HP:0010975) | 8.09415479 |
| 4 | B lymphocytopenia (HP:0010976) | 8.09415479 |
| 5 | Recurrent bronchitis (HP:0002837) | 6.80288128 |
| 6 | Recurrent sinusitis (HP:0011108) | 6.64302918 |
| 7 | Cellulitis (HP:0100658) | 6.16325922 |
| 8 | Gastrointestinal stroma tumor (HP:0100723) | 5.67485714 |
| 9 | Papilloma (HP:0012740) | 5.66220858 |
| 10 | Verrucae (HP:0200043) | 5.66220858 |
| 11 | Abnormality of macrophages (HP:0004311) | 5.38696967 |
| 12 | Abnormality of nail color (HP:0100643) | 5.33990581 |
| 13 | Abnormality of the prostate (HP:0008775) | 5.28474924 |
| 14 | Colitis (HP:0002583) | 5.28274783 |
| 15 | IgM deficiency (HP:0002850) | 5.04440284 |
| 16 | Recurrent pneumonia (HP:0006532) | 4.89148359 |
| 17 | Increased IgE level (HP:0003212) | 4.81069712 |
| 18 | Recurrent viral infections (HP:0004429) | 4.79512819 |
| 19 | Meningitis (HP:0001287) | 4.69404147 |
| 20 | Chronic sinusitis (HP:0011109) | 4.49280802 |
| 21 | Recurrent lower respiratory tract infections (HP:0002783) | 4.21214990 |
| 22 | Thyroiditis (HP:0100646) | 4.05374506 |
| 23 | IgG deficiency (HP:0004315) | 4.01057765 |
| 24 | Chronic otitis media (HP:0000389) | 3.94166843 |
| 25 | Bronchitis (HP:0012387) | 3.83240532 |
| 26 | Osteomyelitis (HP:0002754) | 3.78554129 |
| 27 | Recurrent otitis media (HP:0000403) | 3.74925612 |
| 28 | Inflammation of the large intestine (HP:0002037) | 3.70892092 |
| 29 | Gastrointestinal inflammation (HP:0004386) | 3.56889138 |
| 30 | IgA deficiency (HP:0002720) | 3.56131625 |
| 31 | Panhypogammaglobulinemia (HP:0003139) | 3.53158019 |
| 32 | Sepsis (HP:0100806) | 3.43306520 |
| 33 | Alopecia of scalp (HP:0002293) | 3.37032078 |
| 34 | Systemic lupus erythematosus (HP:0002725) | 3.32874936 |
| 35 | Right ventricular cardiomyopathy (HP:0011663) | 3.26034074 |
| 36 | Emphysema (HP:0002097) | 3.24551527 |
| 37 | Onycholysis (HP:0001806) | 3.22204150 |
| 38 | Abnormality of T cell physiology (HP:0011840) | 3.21003994 |
| 39 | Skin rash (HP:0000988) | 3.13167046 |
| 40 | Abnormality of T cell number (HP:0011839) | 3.05290002 |
| 41 | Abnormality of male internal genitalia (HP:0000022) | 2.99565206 |
| 42 | Autoimmune thrombocytopenia (HP:0001973) | 2.95994415 |
| 43 | Vasculitis (HP:0002633) | 2.95656881 |
| 44 | Abnormality of T cells (HP:0002843) | 2.87343730 |
| 45 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.78751632 |
| 46 | Gangrene (HP:0100758) | 2.77045127 |
| 47 | Hypoplasia of the thymus (HP:0000778) | 2.76823418 |
| 48 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.74910091 |
| 49 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.73642487 |
| 50 | Restrictive lung disease (HP:0002091) | 2.72597036 |
| 51 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.72475031 |
| 52 | Lymphopenia (HP:0001888) | 2.70023816 |
| 53 | Interstitial pulmonary disease (HP:0006530) | 2.69584459 |
| 54 | T lymphocytopenia (HP:0005403) | 2.69156163 |
| 55 | Persistence of primary teeth (HP:0006335) | 2.61377514 |
| 56 | Combined immunodeficiency (HP:0005387) | 2.59582717 |
| 57 | Recurrent fungal infections (HP:0002841) | 2.57352692 |
| 58 | Erythema (HP:0010783) | 2.55307416 |
| 59 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.54196422 |
| 60 | Palmoplantar hyperkeratosis (HP:0000972) | 2.52460225 |
| 61 | Recurrent abscess formation (HP:0002722) | 2.50589460 |
| 62 | Chronic obstructive pulmonary disease (HP:0006510) | 2.48725140 |
| 63 | Obstructive lung disease (HP:0006536) | 2.48725140 |
| 64 | Spontaneous hematomas (HP:0007420) | 2.48090441 |
| 65 | Severe combined immunodeficiency (HP:0004430) | 2.47916761 |
| 66 | Mitral stenosis (HP:0001718) | 2.46392367 |
| 67 | Corneal erosion (HP:0200020) | 2.45909269 |
| 68 | Hyperactive renin-angiotensin system (HP:0000841) | 2.42613954 |
| 69 | Neoplasm of the lung (HP:0100526) | 2.42499362 |
| 70 | Gastrointestinal infarctions (HP:0005244) | 2.42408820 |
| 71 | Hypermelanotic macule (HP:0001034) | 2.42219759 |
| 72 | Recurrent bacterial skin infections (HP:0005406) | 2.37199454 |
| 73 | Vacuolated lymphocytes (HP:0001922) | 2.35994635 |
| 74 | Palmar hyperkeratosis (HP:0010765) | 2.33192834 |
| 75 | Pustule (HP:0200039) | 2.25592077 |
| 76 | Mucosal telangiectasiae (HP:0100579) | 2.19830068 |
| 77 | Plantar hyperkeratosis (HP:0007556) | 2.17636951 |
| 78 | Thick nail (HP:0001805) | 2.16337973 |
| 79 | Orchitis (HP:0100796) | 2.14927854 |
| 80 | Hypotrichosis (HP:0001006) | 2.13551936 |
| 81 | Hemoptysis (HP:0002105) | 2.13049804 |
| 82 | Skin ulcer (HP:0200042) | 2.12656651 |
| 83 | Glomerulonephritis (HP:0000099) | 2.12555323 |
| 84 | Neoplasm of the respiratory system (HP:0100606) | 2.10749232 |
| 85 | Eosinophilia (HP:0001880) | 2.10416336 |
| 86 | Xerostomia (HP:0000217) | 2.09349888 |
| 87 | Pruritus (HP:0000989) | 2.08113315 |
| 88 | Neutropenia (HP:0001875) | 2.06117542 |
| 89 | Recurrent cutaneous fungal infections (HP:0011370) | 2.05790695 |
| 90 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.05790695 |
| 91 | Acrocyanosis (HP:0001063) | 2.05656166 |
| 92 | Recurrent skin infections (HP:0001581) | 2.03327982 |
| 93 | Oral leukoplakia (HP:0002745) | 2.01913009 |
| 94 | Premature loss of primary teeth (HP:0006323) | 1.99903386 |
| 95 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.97850988 |
| 96 | Colon cancer (HP:0003003) | 1.97481202 |
| 97 | Pulmonary infiltrates (HP:0002113) | 1.97453801 |
| 98 | Myositis (HP:0100614) | 1.96435335 |
| 99 | Retrobulbar optic neuritis (HP:0100654) | 1.93428856 |
| 100 | Optic neuritis (HP:0100653) | 1.93428856 |
| 101 | Ectropion (HP:0000656) | 1.93374154 |
| 102 | Gingivitis (HP:0000230) | 1.92422171 |
| 103 | Deep venous thrombosis (HP:0002625) | 1.92158331 |
| 104 | Nephritis (HP:0000123) | 1.91625794 |
| 105 | Hypertensive crisis (HP:0100735) | 1.90350462 |
| 106 | Limb hypertonia (HP:0002509) | 1.89768832 |
| 107 | Abnormality of complement system (HP:0005339) | 1.89581221 |
| 108 | Malnutrition (HP:0004395) | 1.88642846 |
| 109 | Arthralgia (HP:0002829) | 1.86152740 |
| 110 | Lymphoma (HP:0002665) | 1.84673307 |
| 111 | Nonimmune hydrops fetalis (HP:0001790) | 1.84411731 |
| 112 | Abnormality of the intrinsic pathway (HP:0010989) | 1.84241585 |
| 113 | Nasal polyposis (HP:0100582) | 1.81641862 |
| 114 | Pili torti (HP:0003777) | 1.81282070 |
| 115 | Leukopenia (HP:0001882) | 1.79411632 |
| 116 | Hypoproteinemia (HP:0003075) | 1.79397581 |
| 117 | Blepharitis (HP:0000498) | 1.78598668 |
| 118 | Thrombocytosis (HP:0001894) | 1.70146040 |
| 119 | Hypergammaglobulinemia (HP:0010702) | 1.69432458 |
| 120 | Papilledema (HP:0001085) | 1.68408018 |
| 121 | Eczematoid dermatitis (HP:0000976) | 1.66920718 |
| 122 | Bronchiectasis (HP:0002110) | 1.65569991 |
| 123 | Conjunctival hamartoma (HP:0100780) | 1.65488057 |
| 124 | Acute encephalopathy (HP:0006846) | 1.65380180 |
| 125 | Abnormality of eosinophils (HP:0001879) | 1.65299058 |
| 126 | Progressive macrocephaly (HP:0004481) | 1.64147890 |
| 127 | Abnormality of the nasal mucosa (HP:0000433) | 1.62324183 |
| 128 | Teleangiectasia of the skin (HP:0100585) | 1.60631585 |
| 129 | Keratoconjunctivitis sicca (HP:0001097) | 1.60366573 |
| 130 | Acute necrotizing encephalopathy (HP:0006965) | 1.56507333 |
| 131 | Dehydration (HP:0001944) | 1.54587016 |
| 132 | Abnormal gallbladder morphology (HP:0012437) | 1.53821522 |
| 133 | Macroorchidism (HP:0000053) | 1.52738676 |
| 134 | Mediastinal lymphadenopathy (HP:0100721) | 1.52676793 |
| 135 | Cholelithiasis (HP:0001081) | 1.50995422 |
| 136 | Leukocytosis (HP:0001974) | 1.50184671 |
| 137 | Autoimmune hemolytic anemia (HP:0001890) | 1.49429251 |
| 138 | Dysostosis multiplex (HP:0000943) | 1.49074524 |
| 139 | Keratoconjunctivitis (HP:0001096) | 1.48795978 |
| 140 | Urticaria (HP:0001025) | 1.48653921 |
| 141 | Granulocytopenia (HP:0001913) | 1.44203789 |
| 142 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.44149661 |
| 143 | Stomatitis (HP:0010280) | 1.43055830 |
| 144 | Multiple enchondromatosis (HP:0005701) | 1.41906510 |
| 145 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.41146745 |
| 146 | Hyperventilation (HP:0002883) | 1.41099573 |
| 147 | Viral hepatitis (HP:0006562) | 1.40567803 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TESK2 | 7.26032547 |
| 2 | ERN1 | 5.38261999 |
| 3 | MAP4K1 | 5.11336657 |
| 4 | RIPK4 | 3.07695449 |
| 5 | SYK | 2.89000469 |
| 6 | GRK6 | 2.66026111 |
| 7 | GRK1 | 2.53386691 |
| 8 | KIT | 2.51041343 |
| 9 | PRKCH | 2.41803119 |
| 10 | CSF1R | 2.33045085 |
| 11 | BUB1 | 2.24199792 |
| 12 | TYK2 | 2.20214268 |
| 13 | TXK | 2.10163149 |
| 14 | BLK | 2.09115697 |
| 15 | PRPF4B | 2.07108137 |
| 16 | SIK2 | 2.02584466 |
| 17 | LYN | 2.01260081 |
| 18 | SIK3 | 1.99608802 |
| 19 | MAP3K14 | 1.92178713 |
| 20 | TAOK3 | 1.87865395 |
| 21 | BCKDK | 1.85813323 |
| 22 | MST1R | 1.84295110 |
| 23 | BTK | 1.82838811 |
| 24 | PKN2 | 1.80063340 |
| 25 | ZAP70 | 1.79904165 |
| 26 | EIF2AK3 | 1.79274851 |
| 27 | NME2 | 1.75858817 |
| 28 | MAP3K10 | 1.74884612 |
| 29 | MAP3K13 | 1.68175643 |
| 30 | TBK1 | 1.61638958 |
| 31 | IRAK4 | 1.59484089 |
| 32 | ITK | 1.57252682 |
| 33 | FES | 1.53856972 |
| 34 | FLT3 | 1.52472969 |
| 35 | CLK1 | 1.45671880 |
| 36 | PIK3CA | 1.40565305 |
| 37 | PIK3CG | 1.38348064 |
| 38 | PRKCQ | 1.37642042 |
| 39 | MST4 | 1.36472707 |
| 40 | NEK2 | 1.36074094 |
| 41 | MAP3K4 | 1.23583598 |
| 42 | IRAK3 | 1.21818357 |
| 43 | IRAK1 | 1.20264817 |
| 44 | JAK1 | 1.19673590 |
| 45 | HCK | 1.19130581 |
| 46 | FGFR3 | 1.14099830 |
| 47 | FRK | 1.12269264 |
| 48 | MET | 1.10687855 |
| 49 | EPHA3 | 1.08887155 |
| 50 | STK10 | 1.08240538 |
| 51 | MAPKAPK3 | 1.03312327 |
| 52 | MAP3K1 | 1.02783354 |
| 53 | FGFR2 | 1.02636300 |
| 54 | BMX | 1.02445178 |
| 55 | PRKCI | 1.02423181 |
| 56 | RIPK1 | 0.99293054 |
| 57 | HIPK2 | 0.98734535 |
| 58 | SIK1 | 0.97359460 |
| 59 | STK24 | 0.94864201 |
| 60 | LCK | 0.94579802 |
| 61 | PIM1 | 0.92460889 |
| 62 | KDR | 0.89893752 |
| 63 | FGFR4 | 0.87987553 |
| 64 | NEK1 | 0.85794145 |
| 65 | IKBKB | 0.84332204 |
| 66 | EPHB1 | 0.82212562 |
| 67 | TTN | 0.78967855 |
| 68 | MAP3K9 | 0.78888303 |
| 69 | MAP3K3 | 0.78085421 |
| 70 | TAOK1 | 0.77787883 |
| 71 | UHMK1 | 0.77526248 |
| 72 | CSNK1G3 | 0.77474035 |
| 73 | IKBKE | 0.76867644 |
| 74 | FYN | 0.76219079 |
| 75 | BMPR2 | 0.75221524 |
| 76 | TEC | 0.74936463 |
| 77 | LRRK2 | 0.74075950 |
| 78 | MATK | 0.73971383 |
| 79 | MAP3K6 | 0.73110881 |
| 80 | PRKCD | 0.72937951 |
| 81 | PRKD1 | 0.72360732 |
| 82 | BRSK1 | 0.72073231 |
| 83 | NEK9 | 0.71129928 |
| 84 | CSNK1A1L | 0.70473230 |
| 85 | TGFBR2 | 0.69462917 |
| 86 | KSR2 | 0.68174355 |
| 87 | MAP2K3 | 0.68068466 |
| 88 | DDR2 | 0.67342720 |
| 89 | PDGFRA | 0.67208677 |
| 90 | CSK | 0.66258344 |
| 91 | PKN1 | 0.65275843 |
| 92 | ALK | 0.63170779 |
| 93 | RET | 0.62028163 |
| 94 | CSNK1G2 | 0.61727752 |
| 95 | IGF1R | 0.61540411 |
| 96 | JAK3 | 0.59808888 |
| 97 | TAOK2 | 0.57616689 |
| 98 | BCR | 0.56597899 |
| 99 | GRK5 | 0.53611612 |
| 100 | MAPK12 | 0.53222737 |
| 101 | FGR | 0.51778605 |
| 102 | FER | 0.46212842 |
| 103 | MAPK4 | 0.45177417 |
| 104 | CSNK1G1 | 0.42583918 |
| 105 | NME1 | 0.40374819 |
| 106 | PDPK1 | 0.40108006 |
| 107 | JAK2 | 0.39262024 |
| 108 | PDGFRB | 0.39210307 |
| 109 | MAP3K11 | 0.38595263 |
| 110 | RPS6KA6 | 0.38418828 |
| 111 | INSR | 0.37316445 |
| 112 | IRAK2 | 0.37240166 |
| 113 | MAPK7 | 0.35351606 |
| 114 | TRIB3 | 0.34274178 |
| 115 | ABL1 | 0.33749356 |
| 116 | YES1 | 0.33558682 |
| 117 | MAPKAPK2 | 0.33153674 |
| 118 | EEF2K | 0.32780950 |
| 119 | RPS6KL1 | 0.32740756 |
| 120 | RPS6KC1 | 0.32740756 |
| 121 | ACVR1B | 0.32608236 |
| 122 | PRKCZ | 0.32122678 |
| 123 | CDC42BPA | 0.31427948 |
| 124 | NTRK1 | 0.31406211 |
| 125 | TAF1 | 0.31189388 |
| 126 | PDK1 | 0.31169299 |
| 127 | CDK15 | 0.30858285 |
| 128 | MARK3 | 0.30427546 |
| 129 | PDK2 | 0.30230300 |
| 130 | NTRK3 | 0.28878966 |
| 131 | EIF2AK2 | 0.28308344 |
| 132 | CCNB1 | 0.28281116 |
| 133 | ARAF | 0.28218229 |
| 134 | TGFBR1 | 0.28137283 |
| 135 | EGFR | 0.27724676 |
| 136 | EPHA2 | 0.27228280 |
| 137 | MAP3K8 | 0.25091929 |
| 138 | CDK18 | 0.24870360 |
| 139 | MAPK11 | 0.23853933 |
| 140 | RPS6KB2 | 0.23013652 |
| 141 | CDK5 | 0.21064459 |
| 142 | VRK1 | 0.20592963 |
| 143 | CAMKK1 | 0.20506621 |
| 144 | SRC | 0.20190809 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 9.08251862 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.80533086 |
| 3 | Protein export_Homo sapiens_hsa03060 | 4.38604900 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.69300468 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.50158024 |
| 6 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.34003515 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.11191594 |
| 8 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.93301004 |
| 9 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.84560656 |
| 10 | DNA replication_Homo sapiens_hsa03030 | 1.65078931 |
| 11 | Asthma_Homo sapiens_hsa05310 | 1.63545496 |
| 12 | Influenza A_Homo sapiens_hsa05164 | 1.54624774 |
| 13 | Proteasome_Homo sapiens_hsa03050 | 1.50593794 |
| 14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.44834805 |
| 15 | Allograft rejection_Homo sapiens_hsa05330 | 1.31966336 |
| 16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.31195477 |
| 17 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.29855555 |
| 18 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.29717280 |
| 19 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.28867651 |
| 20 | Phagosome_Homo sapiens_hsa04145 | 1.28322136 |
| 21 | Leishmaniasis_Homo sapiens_hsa05140 | 1.25717353 |
| 22 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.21117333 |
| 23 | Base excision repair_Homo sapiens_hsa03410 | 1.20317415 |
| 24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.20117486 |
| 25 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.19714614 |
| 26 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.19638719 |
| 27 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.17538613 |
| 28 | Mismatch repair_Homo sapiens_hsa03430 | 1.09278330 |
| 29 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.06161807 |
| 30 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.05983568 |
| 31 | Other glycan degradation_Homo sapiens_hsa00511 | 1.03167546 |
| 32 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.00672286 |
| 33 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.98302141 |
| 34 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.97057588 |
| 35 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.96386007 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.94646402 |
| 37 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.91936393 |
| 38 | Hepatitis C_Homo sapiens_hsa05160 | 0.91800159 |
| 39 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.91065143 |
| 40 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.85942442 |
| 41 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.85286264 |
| 42 | Homologous recombination_Homo sapiens_hsa03440 | 0.85211478 |
| 43 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.84340238 |
| 44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.83532959 |
| 45 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.82980305 |
| 46 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.81872048 |
| 47 | Viral myocarditis_Homo sapiens_hsa05416 | 0.81801435 |
| 48 | Tuberculosis_Homo sapiens_hsa05152 | 0.81434956 |
| 49 | Malaria_Homo sapiens_hsa05144 | 0.80548808 |
| 50 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.76870695 |
| 51 | Pertussis_Homo sapiens_hsa05133 | 0.76250114 |
| 52 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.76179680 |
| 53 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.72831334 |
| 54 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.72053223 |
| 55 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.71572249 |
| 56 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.70710854 |
| 57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.70688937 |
| 58 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.68048715 |
| 59 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.67360447 |
| 60 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.67028503 |
| 61 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.65631098 |
| 62 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.65116623 |
| 63 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.64480385 |
| 64 | Long-term potentiation_Homo sapiens_hsa04720 | 0.62917216 |
| 65 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.62181618 |
| 66 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.60774997 |
| 67 | Amoebiasis_Homo sapiens_hsa05146 | 0.60443363 |
| 68 | Alzheimers disease_Homo sapiens_hsa05010 | 0.59081217 |
| 69 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.59015608 |
| 70 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.58728435 |
| 71 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.58382718 |
| 72 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.58064569 |
| 73 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.57991386 |
| 74 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.57493886 |
| 75 | Phototransduction_Homo sapiens_hsa04744 | 0.56777101 |
| 76 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.56320984 |
| 77 | Lysosome_Homo sapiens_hsa04142 | 0.55711888 |
| 78 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.54993071 |
| 79 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.54024567 |
| 80 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.53843905 |
| 81 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.53687852 |
| 82 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.53407714 |
| 83 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.53059511 |
| 84 | Salmonella infection_Homo sapiens_hsa05132 | 0.49843579 |
| 85 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.49683336 |
| 86 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.49115873 |
| 87 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.48987124 |
| 88 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.48766892 |
| 89 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.47640943 |
| 90 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.46834400 |
| 91 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.45909587 |
| 92 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.45168123 |
| 93 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.42606939 |
| 94 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.40462059 |
| 95 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.40125008 |
| 96 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.40045542 |
| 97 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.38937505 |
| 98 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.38335157 |
| 99 | Histidine metabolism_Homo sapiens_hsa00340 | 0.38043340 |
| 100 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.36628998 |
| 101 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36501156 |
| 102 | Shigellosis_Homo sapiens_hsa05131 | 0.36287792 |
| 103 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.34140049 |
| 104 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.34057942 |
| 105 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.33509255 |
| 106 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.31319693 |
| 107 | Legionellosis_Homo sapiens_hsa05134 | 0.30635270 |
| 108 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.30573105 |
| 109 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.30554672 |
| 110 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.30115499 |
| 111 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.29993250 |
| 112 | Renin secretion_Homo sapiens_hsa04924 | 0.29809834 |
| 113 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.28912101 |
| 114 | Measles_Homo sapiens_hsa05162 | 0.28107744 |
| 115 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.27815464 |
| 116 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.27672656 |
| 117 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.27581315 |
| 118 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.27535548 |
| 119 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.27256449 |
| 120 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.26627980 |
| 121 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.25999087 |
| 122 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.25286837 |
| 123 | Circadian entrainment_Homo sapiens_hsa04713 | 0.25212070 |
| 124 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.25206282 |
| 125 | Glioma_Homo sapiens_hsa05214 | 0.25053587 |
| 126 | Ribosome_Homo sapiens_hsa03010 | 0.24928666 |
| 127 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.24892498 |
| 128 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.24333689 |
| 129 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.24198854 |
| 130 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.23797844 |
| 131 | Hepatitis B_Homo sapiens_hsa05161 | 0.23155996 |
| 132 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.22305349 |
| 133 | Peroxisome_Homo sapiens_hsa04146 | 0.22220068 |
| 134 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.22133461 |
| 135 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.21870867 |
| 136 | Insulin resistance_Homo sapiens_hsa04931 | 0.21488872 |
| 137 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.20902730 |
| 138 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.20578198 |
| 139 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.20108890 |
| 140 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.18569168 |
| 141 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.18110247 |
| 142 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.17637994 |
| 143 | Platelet activation_Homo sapiens_hsa04611 | 0.17521375 |
| 144 | HTLV-I infection_Homo sapiens_hsa05166 | 0.16849860 |
| 145 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.16783560 |
| 146 | Cocaine addiction_Homo sapiens_hsa05030 | 0.16753451 |
| 147 | Apoptosis_Homo sapiens_hsa04210 | 0.16094284 |
| 148 | Carbon metabolism_Homo sapiens_hsa01200 | 0.15520964 |

